Accord Healthcare launches Herceptin biosimilar in the UK
Zercepac will be available for HER2-positive breast and gastric cancers
Read More
Tag: Accord Healthcare
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
